All Stories

  1. FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models
  2. Editorial introducing the Research Topic on alpha-Synuclein in Frontiers in Neuroscience
  3. Seeking Biomarkers and Therapies for Parkinson’s Disease and Multiple System Atrophy
  4. Making cells healthier with our patented compounds
  5. Parkinsonian GM2 synthase knockout mice lacking mature gangliosides develop urinary dysfunction and neurogenic bladder
  6. Up-regulation of protective neuronal MicroRNAs by FTY720 and novel FTY720-derivatives
  7. Could α-Synuclein Modulation of Insulin and Dopamine Identify a Novel Link Between Parkinson’s Disease and Diabetes as Well as Potential Therapies?
  8. Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
  9. FTY720 (Fingolimod) reverses α-synuclein-induced downregulation of brain-derived neurotrophic factor mRNA in OLN-93 oligodendroglial cells
  10. Safer compounds for Parkinson's disease and related disorders
  11. FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice